Chemoinformaics analysis of 1,2,3,4-Tetramethylcyclohexane
Molecular Weight | 140.27 | nRot | 0 |
Heavy Atom Molecular Weight | 120.11 | nRig | 6 |
Exact Molecular Weight | 140.156 | nRing | 1 |
Solubility: LogS | -5.067 | nHRing | 0 |
Solubility: LogP | 4.149 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 30 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 1 |
No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 10 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
nHA | 0 | APOL | 30.0359 |
nHD | 0 | BPOL | 20.0641 |
QED | 0.484 |
Synth | 3.376 |
Natural Product Likeliness | 0.771 |
NR-PPAR-gamma | 0.002 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.001 |
Pgp-sub | 0.001 |
HIA | 0.004 |
CACO-2 | -4.378 |
MDCK | 0.0000132 |
BBB | 0.738 |
PPB | 0.951952 |
VDSS | 2.249 |
FU | 0.0424737 |
CYP1A2-inh | 0.79 |
CYP1A2-sub | 0.793 |
CYP2c19-inh | 0.085 |
CYP2c19-sub | 0.945 |
CYP2c9-inh | 0.318 |
CYP2c9-sub | 0.258 |
CYP2d6-inh | 0.006 |
CYP2d6-sub | 0.439 |
CYP3a4-inh | 0.27 |
CYP3a4-sub | 0.597 |
CL | 15.255 |
T12 | 0.178 |
hERG | 0.011 |
Ames | 0.09 |
ROA | 0.074 |
SkinSen | 0.09 |
Carcinogencity | 0.112 |
EI | 0.98 |
Respiratory | 0.169 |
NR-Aromatase | 0.002 |
Antiviral | No |
Prediction | 0.935317 |